We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Bionovate Technologies Corporation (CE) | USOTC:BIIO | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.00 | 01:00:00 |
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the quarterly period ended December 31, 2016
|
|
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the transition period from to
|
Yes [X] No [ ]
|
Yes [X] No [ ]
|
Large accelerated filer
|
[ ]
|
Accelerated filer
|
[ ]
|
Non-accelerated filer
|
[ ]
|
Smaller reporting company
|
[X]
|
(Do not check if a smaller reporting company)
|
Yes [ ] No [ X ]
|
Yes [ ] No [ ]
|
12,970,000 common shares issued and outstanding
as of
February 16, 2017.
|
(Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.)
|
Page
|
||
PART I – Financial Information
|
||
Item 1.
|
Financial Statements
|
3 |
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
17 |
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
24 |
Item 4.
|
Controls and Procedures
|
24 |
PART II – Other Information
|
||
Item 1.
|
Legal Proceedings
|
25 |
Item 1A.
|
Risk Factors
|
25 |
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
25 |
Item 3.
|
Defaults Upon Senior Securities
|
25 |
Item 4.
|
Mine Safety Disclosures
|
25 |
Item 5.
|
Other Information
|
25 |
Item 6.
|
Exhibits
|
25 |
Signatures
|
26 |
Exhibit
Number
|
Description
|
(3)
|
Articles of Incorporation and Bylaws
|
3.1
|
Articles of Incorporation (incorporated by reference to our Registration Statement on Form S-1 filed on April 26, 2013).
|
3.2
|
Bylaws (incorporated by reference to our Registration Statement on Form S-1 filed on April 26, 2013).
|
(31)
|
Rule 13a-14(a)/15d-14(a) Certification
|
31.1*
|
Section 302 Certification under Sarbanes-Oxley Act of 2002 of the Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer
|
(32)
|
Section 1350 Certifications
|
32.1*
|
Section 906 Certification under Sarbanes-Oxley Act of 2002 of the Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer
|
101
*
|
Interactive Data Files
|
101.INS*
|
XBRL Instance Document
|
101.SCH*
|
XBRL Taxonomy Extension Schema Document
|
101.CAL*
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
101.DEF*
|
XBRL Taxonomy Extension Definition Linkbase Document
|
101.LAB*
|
XBRL Taxonomy Extension Label Linkbase Document
|
101.PRE*
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
*
|
Filed herewith.
|
MJP INTERNATIONAL LTD.
|
||
(Registrant)
|
||
Dated: February 22, 2017
|
By:
|
/s/ Liao Zu Guo
|
Liao Zu Guo
|
||
President, Chief Executive Officer and Director
|
||
(Principal Executive Officer, Principal Financial
|
||
Officer and Principal Accounting Officer)
|
1 Year Bionovate Technologies (CE) Chart |
1 Month Bionovate Technologies (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions